Compass Therapeutics, Inc. (CMPX)
6.17
-0.22
(-3.44%)
USD |
NASDAQ |
Feb 20, 15:54
Compass Therapeutics Shareholders Equity (Quarterly) : 209.61M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Arcutis Biotherapeutics, Inc. | 158.07M |
| ImmunityBio, Inc. | -524.32M |
| Biohaven Ltd. | -17.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 231.26M |
| Total Liabilities (Quarterly) | 21.65M |
| Debt to Equity Ratio | 0.0471 |
| Current Ratio | 17.82 |
| Net Debt Paydown Yield | -0.28% |